Phathom Pharmaceuticals, Inc.
← Back to PHAT Overview

Phathom Pharmaceuticals, Inc. (PHAT)

Profitability & Net Margin History

Current Net Margin

-36.73%

Phathom Pharmaceuticals, Inc. currently has a net profit margin of -36.73%.

Financial Fundamentals

PHATQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.06-0.02-36.73%2382
2025-09-300.05-0.03-60.55%13136
2025-06-300.04-0.08-191.91%13880
2025-03-310.03-0.09-330.71%7973
2024-12-310.03-0.07-250.98%27236
2024-09-300.02-0.09-523.34%72524
2024-06-300.01-0.09-1248.58%308468
2024-03-310.00-0.08-4333.26%733375
2023-12-310.00-0.08-11667.01%
2023-09-300.00-0.04
2023-06-300.00-0.04
2023-03-310.00-0.04
2022-12-310.00-0.06
2022-09-300.00-0.05
2022-06-300.00-0.05
2022-03-310.00-0.04
2021-12-310.00-0.04
2021-09-300.00-0.04
2021-06-300.00-0.04
2021-03-310.00-0.03
2020-12-310.00-0.05
2020-09-300.00-0.03
2020-06-300.00-0.02
2020-03-310.00-0.02
2019-12-310.00-0.10
2019-09-300.00-0.07
2019-06-300.00-0.09
2019-03-310.00-0.00
2018-12-310.00-0.00
2018-09-300.00-0.00
2018-06-300.00-0.00
2018-03-310.00-0.00

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.